The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 19th 2025
New research highlights the effectiveness and safety of RSV vaccines for older adults, revealing critical insights into vaccination benefits and risks.
FDA Approves Continuous Glucose Monitoring System for Diabetes
September 28th 2017Officials with the FDA have approved FreeStyle Libre Flash Glucose Monitoring System (Abbot Diabetes Care Inc.), the first continuous glucose monitoring system for adult patients that reduces the need for fingerstick testing.
Read More
Beauty Product Manufacturer to Cease Distribution of Unapproved Drugs
September 27th 2017A New Jersey company that sold injectable skin whitening and other beauty products has been ordered to stop selling and recall some of its products because they are unapproved new drugs that are potentially unsafe to consumers, according to the FDA's press release.
Read More
Influenza Vaccine: Safe Storage Tips
September 22nd 2017In the video, JoEllen Wolicki, a nurse educator with the CDC, notes that that CDC recommends an “in purpose-built unit specifically designed for the storage of biologics, or if necessary, a stand alone household refrigerator” to store flu vaccines.
Read More
FDA Alert: Reduce Risks of Combined Use of Opioid Addiction Medications and CNS Depressants
September 21st 2017FDA officials have issued a drug safety communication advising that buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other central nervous system (CNS) depressants.
Read More
5-FU Toxicity and DPD: A New Option to Treat Pyrimidine Analogue Overdose
September 21st 20175-Fluorouracil is the mainstay of treatment for many cancers, with upwards of 30% rates of adverse effects. DPD deficiency can further amplify these effects and even lead to life-threatening toxicity. Uridine triacetate is FDA approved for 5-FU and capecitabine overdose treatment within 96 hours of administration.
Read More
FDA Approves First Once-Daily Single Inhaler Triple Therapy for COPD
September 19th 2017Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Read More